Sentences with phrase «current years dividend growth»

Using the current years Dividend Growth rate of 2 % and projecting 2 % forward the annual dividend income in 10 yrs would be $ 0.00 with a yield on cost % of 3.00 %

Not exact matches

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
This table shows the annual rate of LAZ's dividend growth since its current streak of 10 years started.
In a fairly poor scenario, even if only a 5.7 % long - term EPS / dividend growth rate is achieved (chosen to match the previous 7 - year average EPS growth), then the current price in the low $ 80's can still offer a 9 % long - term rate of return, based on the DDM again.
The current yield of 1.55 % might not be massive like AT&T's dividend (which is why we diversify, and it's why I'm listing 10 different stocks with different dynamics here), but Walt Disney more than makes up for that via strong dividend growth: the five - year dividend growth rate is 30.1 %, which is one of the higher rates you'll run across.
If the current dividend yield is stable through the years and there is dividend growth, this also implies that on top of receiving more dividend income, your holding has also grown in value.
If I assume a dividend growth rate of 6 percent (about the long - run average *), the current S&P 500 dividend yield of 2.1 percent (from multpl.com), a terminal S&P 500 dividend yield of 4 percent (Hussman says that the dividend yield on stocks has historically averaged about 4 percent), the expected nominal return over ten years is 2.4 percent annually.
As such, dividend growth in the next few years certainly won't match that last few, but I'm very content with that given the exceedingly high current yield, my high confidence in Textainer to ride the storm through to better times, and ultra-safe P / E and reasonable payout ratio.
As you can see many of the stocks mentioned may have high current PE's but also feature long to very long dividend histories with relatively high ten year annualized dividend growth rates at around or better than 10 %.
Some sources use the current dividend compared to that from 5 years ago and then annualise the growth.
Finally, my current favourite is Canadian Tire (CTC.A, $ 56.38), which pays a 1.5 % dividend yield, sports a price - to - earnings ratio of 13.5, and a five - year annual dividend growth rate of 10.9 %.
They have a reasonable payout ratio of 49.5 %, the current yield is a very healthy 3.4 % and the 5 year dividend growth rate is 5.8 % (6.9 % if we count 2015, see below).
Assuming that the current dividend payout ratios and earnings growth rates stay approximately constant in the future, the ETF should return about 11 % per year in total.
While I wouldn't expect that kind of dividend growth to continue on for the foreseeable future, as much of this growth was propelled by a growing payout ratio, the current payout ratio of 45.3 % still leaves a lot of room for continued dividend increases, even increases that exceed the rate of underlying profit growth for the next few years.
The current yield of 1.55 % might not be massive like AT&T's dividend (which is why we diversify, and it's why I'm listing 10 different stocks with different dynamics here), but Walt Disney more than makes up for that via strong dividend growth: the five - year dividend growth rate is 30.1 %, which is one of the higher rates you'll run across.
- Seven Year Revenue Growth Rate: 5.8 % - Seven Year EPS Growth Rate: 9.4 % - Seven Year Dividend Growth Rate: 14.9 % - Current Dividend Yield: 2.43 % - Balance Sheet: Reasonable Leverage, Stable Currently, Walmart's $ 77 share price appears to be fairly valued for an expectation of 10 % long - term returns.
If the current dividend yield is stable through the years and there is dividend growth, this also implies that on top of receiving more dividend income, your holding has also grown in value.
Therefore, it is simple to estimate the 10 - year market return by combining three components: 6 % growth in fundamentals, reversion in the Shiller P / E toward 15 over a 10 - year period, and the current dividend yield.
If I assume a dividend growth rate of 6 percent (about the long - run average *), the current S&P 500 dividend yield of 2.1 percent (from multpl.com), a terminal S&P 500 dividend yield of 4 percent (Hussman says that the dividend yield on stocks has historically averaged about 4 percent), the expected nominal return over ten years is 2.4 percent annually.
- Seven Year Revenue Growth Rate: 10.5 % Dividend Stock Report - Seven Year EPS Growth Rate: 7.3 % - Seven Year Dividend Growth Rate: 11.2 % - Current Dividend Yield: 2.84 % - Balance Sheet: Stable
Above - average current yield and expectations for above - average earnings growth out to fiscal year - end 2018 makes slow - growing high - yielding SCANA an intriguing dividend growth stock opportunity.
Over the past 15 years under current management, the T. Rowe Price Dividend Growth fund delivered unimpressive results on a truly risk - adjusted basis.
I agree that the ROE isn't stellar, averaging 9 % over the past three years, but I do think the low valuation, strong balance sheet, and most importantly the potential dividend growth merit your consideration (current dividend payout is just 32 % of 2013 EPS estimates, and ideally they'd continue their strong recent series of increases).
After the three stock acquisitions (Britvic, ReckitBenkisser and Imperial Brands) and due to further organic dividend growth on my existing positions, my current projected dividend income for the year now is well above USD 6» 000, one third higher than in the previous year (2017: USD 4» 500).
With a dividend growth compound annual growth rate of 16.95 % and 18.37 % over the last 10 and 5 years, respectively, this stock is a fantastic buy at current prices.
Although the company hasn't delivered much in dividend growth over the last five years, it still boasts a terrific current yield of 5.2 %.
Combining 7 % -9 % projected annual earnings growth with a 2.8 % current dividend yield, this would result in total returns of 10 % + per year.
Five Year Revenue Growth: < 1 % EPS Growth: Low or Negative Five Year Growth of Book Value: 7 % Dividend Yield: 5.64 % Five Year Annual Dividend Growth Rate: 15 % Price - to - Book: 0.93 I find HGIC to be a solid value at the current price, with a sustainable and large dividend yield, and a solid financial coDividend Yield: 5.64 % Five Year Annual Dividend Growth Rate: 15 % Price - to - Book: 0.93 I find HGIC to be a solid value at the current price, with a sustainable and large dividend yield, and a solid financial coDividend Growth Rate: 15 % Price - to - Book: 0.93 I find HGIC to be a solid value at the current price, with a sustainable and large dividend yield, and a solid financial codividend yield, and a solid financial condition.
Since the current payout ratios are slightly higher than the company's historical average, investors should probably expect annual dividend growth that's slightly less than EPS and FCF growth, along the lines of 6 % to 8 % a year.
The long - term growth rate has been something like 12 % a year and the current dividend yield is just below 5 %.
a b c d e f g h i j k l m n o p q r s t u v w x y z